Clinical trials
Outcome Assessment clinical trials
Below are recruiting outcome assessment clinical trials, each written for real people, not researchers. We’re tracking 163 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06863545Recruiting
PCSK9 Inhibitors for High-Risk Coronary Plaques on CT
This study tests whether adding a PCSK9 inhibitor (a newer cholesterol-lowering shot) to standard treatment can reduce heart risks in people who have certain high-risk plaque features seen on a CT scan of their heart arteries.
Hangzhou, ZhejiangAges 18 years+ - NCT06941025Recruiting
Safety of Elfabrio in pregnant and breastfeeding women with Fabry disease
This study follows women with Fabry disease who took the medicine Elfabrio during pregnancy or breastfeeding to see if it is safe for them and their babies. It helps doctors learn more about how this treatment affects mothers and infants.
Washington D.C., District of ColumbiaAges Any age - NCT07243834Recruiting
Digital exercise program for prostate cancer patients on hormone therapy
This trial tests a digital exercise program to see if it helps men with prostate cancer stay active while on hormone therapy. You may be able to join if you're starting or already on hormone therapy and also getting radiation therapy.
LondonAges 18 years+ - NCT02269592Recruiting
Study blood marker changes in early, symptom-free blood cancers
This study follows people with early, “precursor” blood conditions to learn what changes in their blood or bone marrow signal progression. It may help doctors better predict outcomes and understand why some people develop symptom-causing cancer.
Boston, MassachusettsAges 18 years+ - NCT07425496Recruiting
Eye fluid dynamics study during surgery
This trial measures eye fluid flow during cataract or glaucoma surgery. It aims to help doctors predict and improve surgery results.
New York, New YorkAges 18 years+ - NCT04253964RecruitingPhase 2
Chemotherapy plus immunotherapy for advanced lung cancer
This study tests a combination of chemotherapy and immunotherapy in people with advanced non-small cell lung cancer that has spread or cannot be removed with surgery. The goal is to see how well this treatment works in patients with different levels of daily activity.
Winston-Salem, North CarolinaAges 18 years+ - NCT07775976Enrolling by invitation
Cor360: Clinician-Facing Broad-Spectrum Cardiac Phenotyping and Risk Assessment Using COR® Wearable ECG to Inform Outcomes-Oriented Care Pathways
Pasadena, CaliforniaAges 18 years+ - NCT06539312Recruiting
School program to help manage asthma
This trial tests a program that partners with schools to help children manage asthma better. It aims to improve asthma control and reduce hospital visits.
Buffalo, New YorkAges 4–13 - NCT06811103Recruiting
How chronic pain patients make decisions about treatment
This study looks at what helps people with chronic pain make choices about their treatment. You will be asked some questions during your first pain clinic visit to see how your decision-making relates to how well treatments work.
Paris, ParisAges 18 years+ - NCT06816563Recruiting
Predicting success of turning a breech baby
This trial studies a special ultrasound measurement called the 'breech progression angle' to see if it can predict whether a doctor can safely turn a breech baby into a head-down position using gentle pressure on the belly (external cephalic version).
Bologna, BolognaAges 18–45 - NCT05315596Enrolling by invitation
Tracking pain and recovery answers after surgery
This study checks how patients report pain and recovery over time after surgery. It may help improve how hospitals understand and manage pain after operations.
JenaAges 18 years+ - NCT06551194Recruiting
Studying hard-to-treat inflammatory bowel disease
This study looks at people with inflammatory bowel disease (IBD) that is hard to manage. Researchers want to understand how common it is, how it is treated, and what happens over time.
MilanAges 18–69 - NCT05374291Enrolling by invitationPhase 3
Dapagliflozin trial for kidney and heart outcomes in severe CKD
This study tests whether dapagliflozin can improve kidney and heart-related outcomes in people with severe chronic kidney disease (CKD). You would take the study medicine (or a comparison treatment) and be followed to see how your kidneys and heart do over time.
Canberra, Australian Capital TeritoryAges 18 years+ - NCT06870617Recruiting
Study on geriatric assessment for older adults with advanced cancer
This trial looks at using a practical geriatric assessment to help guide treatment for people aged 70 and older with advanced solid tumors. The goal is to see if this assessment improves care and outcomes.
Princeton, New JerseyAges 70 years+ - NCT05489705Recruiting
Real-world registry for mavacamten and other obstructive HCM treatments
This study collects real-world information about people with obstructive hypertrophic cardiomyopathy (HCM) who are being treated with mavacamten or other standard medicines. It aims to understand patient characteristics, treatment choices over time, and long-term outcomes.
Anchorage, AlaskaAges 18 years+ - NCT04381663Enrolling by invitation
Tracking symptoms in degenerative neck spine narrowing
This study follows adults with degenerative narrowing in the neck spine to see how symptoms and function change over time. It may help doctors better understand which patients improve or worsen, and why.
BaselAges 18 years+ - NCT05858398Recruiting
How body composition affects chemotherapy results in breast cancer
This study looks at whether body fat and muscle (body composition) change how well certain chemotherapy works after surgery for early breast cancer. You may be considered if you are planned to receive docetaxel as adjuvant (after-surgery) chemotherapy and have recent CT scan images.
RouenAges 18 years+ - NCT06886087Recruiting
Studying kidney fat and donor kidney health
This study asks whether the amount of fat around your kidney before donation can predict how your remaining kidney will do afterward. It follows living donors to see if that fat measurement relates to long-term kidney health.
Rochester, MinnesotaAges 18–80 - NCT07559903Recruiting
Drug-coated balloon heart artery treatment registry
This study tracks outcomes in adults who receive a special balloon catheter (coated with medication) to open blocked heart arteries. Researchers collect data to understand how well this treatment works and any side effects that occur.
Phoenix, ArizonaAges 18 years+ - NCT06986447Enrolling by invitation
Non-invasive tests for serious liver disease
This study is testing whether advanced imaging and other non-invasive methods can properly identify people with significant liver scarring due to metabolic liver disease or alcohol-related liver disease. It may help find better ways to track liver health without repeated needle biopsies.
Chandler, ArizonaAges 18–80 - NCT07505758Recruiting
Recovery after surgery in adults 80 and older
This study looks at how well adults aged 80 or older recover after planned surgery that requires an overnight hospital stay. The goal is to understand recovery using a simple questionnaire.
Barcelona, BarcelonaAges 80 years+ - NCT07424586RecruitingEarly Phase 1
Better recovery for older adults with ostomy surgery
This study tests a program to help adults aged 65 and older recover well after ostomy surgery (a surgery that creates an opening on the belly for waste to leave the body). It also involves their healthcare providers.
Boston, MassachusettsAges 18 years+ - NCT04633655Recruiting
Study tests nerve side effects from certain chemotherapy drugs
This study looks at how chemotherapy that can affect nerves (“neurotoxic” chemo) changes nerve function over time. It may help researchers better measure nerve side effects and improve care for people who need these cancer treatments.
Birmingham, AlabamaAges 18 years+ - NCT04021485Recruiting
Smaller steroid dose test for early-born children’s brain outcomes
This study checks whether giving a lower dose of a steroid medicine (betamethasone) to mothers before birth produces similar brain and thinking outcomes in children born very early (before 32 weeks). It may help reduce medicine exposure while keeping developmental results the same.
Paris, PaAges 5–6
Hear when a new Outcome Assessment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for outcome assessment?
- Yes. Clin2 currently lists 163 recruiting outcome assessment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a outcome assessment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a outcome assessment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.